The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
Volume: 59, Issue: 1, Pages: 256 - 258
Published: Jun 2, 2017
Abstract
Ribavirin, an antiviral drug used to treat infections including respiratory syncytial virus (RSV), interferes with the function of the eukaryotic translation initiation factor 4E (eIF4E) [1]....
Paper Details
Title
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
Published Date
Jun 2, 2017
Volume
59
Issue
1
Pages
256 - 258
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History